TheraSphere®, Novel Liver Cancer Therapy, Debuts in India
For the first time, MDS Nordion’s innovative primary liver cancer treatment TheraSphere® have been used in India.
MDS Nordion is a leading global provider of medical isotopes and radiopharmaceuticals (used to diagnose and treat diseases) and is one of 89 Ontario-based companies and organizations participating in a trade mission to India, organized by the Government of Ontario.
- Three patients were the first to be treated for primary liver cancer in India using TheraSphere®
- Two of the successful infusions were conducted at the Lilavati Hospital and Research Centre.
- The third was performed at the Jaslok Hospital and Research Centre. Both centres are located in Mumbai, India. TheraSphere® will be used in India to treat both primary and secondary liver cancers.
TheraSphere®, comprised of tiny radioactive glass beads, delivers a therapeutic dose of radiation to cancerous tumours directly by injecting into the main artery of the patient’s liver using a catheter.
Such way minimizes damage to the patient’s healthy tissues unlike conventional cancer therapy.
Find more details from the full report (a pdf file)
Tags: cancer-therapy, India, liver-cancer, MDS-Nordion, primary-liver-cancer, TheraSphereRelated Stories
POSTED IN: on anti-cancer ingredients, on cancer diagnostics, on liver cancer
0 opinions for TheraSphere®, Novel Liver Cancer Therapy, Debuts in India
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: